STRENKARA Canadian Trademark Information
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants, and pharmaceutical antibody; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents.
Perfect for these industries
Words that describe this mark
pharmaceutical preparations human use treatment prevention obesity diabetes incontinence cardiovascular diseases stroke cancer respiratory diseases autoimmune diseases solid organ transplant rejection pharmaceutical preparations human use antibiotics
Abandonment Notice!
On Wednesday, January 6, 2010,
status on the STRENKARA
trademark changed to Interruption of proceeding.
Apply Now for this name starting at $449!
CAUTION: Although Canada registration for this particular filing is inactive,
the mark may still enjoy common law rights, or may have been applied for again in a separate application.
Further research may be warranted to determine where this mark is truly abandoned in commerce.
On Monday, December 19, 2005, a canadian trademark registration was filed for
STRENKARA by Bristol-Myers Squibb Company
( *********, **********, ***** ****.
The Canadian IP office has given the trademark application number of
1283531.
The current status of this trademark filing is Interruption of proceeding.
The correspondent listed for
STRENKARA is
GOWLING WLG (CANADA) LLP of *********, **********, ***** ****
The STRENKARA
trademark is filed in the description of
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, respiratory diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants, and pharmaceutical antibody; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information